Page 8 - Thyrocare Technologies News Today

The diagnostics industry led by national-level players like Lal Pathlabs, Metropolis Healthcare, Thyrocare Technologies, SRL, Vijaya Diagnostic Centre, Krsnaa Diagnostics, saw a sharp 74% jump in revenue in April-September

(Bloomberg) -- The first pill to treat Covid-19 is on its way and vaccine producers are rolling out booster shots in wealthy countries. For investors, the next stage of the pandemic means a tougher landscape for stockpicking. The success of Merck & Co.’s oral antiviral treatment in a clinical trial has shifted the momentum in the stock market, weighing on shares of the companies that developed the most effective vaccines, Moderna Inc. and the duo of Pfizer Inc. and BioNTech SE. Nineteen months...

The representation is being given by South Chemists & Distributors Association (SCDA) which says that the proposed acquisition needs to be rejected by the CCI Allowing PharmEasy to acquire Thyrocare which has a wide presence in the diagnostics market would give the company an unfair advantage, said the SCDA Besides calling epharmacies illegal, the SCDA also claimed that the only reason for the adoption of epharmacies is that they offer discounts Healthtech unicorn PharmEasy’s proposed acquisi...

Will Section 66A finally be laid to rest? Want this newsletter delievered to your inbox? SUBSCRIBE Thank you for subscribing to Unwrapped Well soon meet in your inbox. / Unwrapped Last Monday, the Supreme Court of India said it was “shocked” that police across the country continue to charge people under Section 66A of the Information Technology Act, a law it struck down as unconstitutional in March 2015. “You file a counter as it is a shocking state of affairs,” Justice Rohinton Fali...

Conquering outpatient care: can Thyrocare help PharmEasy cement its top position in digital health? ✖ From left, Siddharth Shah, cofounder & CEO, API Holdings Ltd shakes hands with A Velumani, chairman & managing director, Thyrocare after signing the agreement of acquisition; image courtesy of PharmEasy Synopsis PharmEasy seems to have cemented its position as India’s largest online pharmacy firm with the addition of Thyrocare. It now has a diversified portfolio of offerings and a strong ...

ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare deal SECTIONS Last Updated: Jun 28, 2021, 08:08 AM IST Share Synopsis PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare. ETtech The Pharmeasy-Thyrocare deal will allow the online pharmacy to offer four key elements of healthcare—information, consult, test ...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your c...

NTPC: The state-owned power giant said it has set a target to install 60 gigawatts (GW) of renewable energy (RE) capacity by 2032. NTPC has become Indias first energy company to declare its energy compact goals as part of the UN High-level Dialogue on Energy (HLDE). InterGlobe Aviation: The parent of the countrys largest airline IndiGos shareholders have approved a proposal to raise up to Rs 3,000 crore. The funds would be raised through the Qualified Institutional Placement route. Thryocare Te...

Stocks in news: NTPC, Orchid Pharma, Ashok Leyland, Vedanta, PNB Housing, Cadila and more Stocks in news: NTPC, Orchid Pharma, Ashok Leyland, Vedanta, PNB Housing, Cadila and more Sensex Nifty open higher Updated Jun 28, 2021, 9:58 AM IST Sensex and Nifty opened higher in trade today. While Sensex rose 132 points to 53,058, Nifty gained 43 points to 15,903. On Friday, the 30-share Sensex jumped 226 points to end at a fresh lifetime high. Sensex closed 226.04 points or 0.43 % higher at 5...

InterGlobe Aviation shareholders have approved a proposal to raise up to Rs 3,000 crore The domestic stock markets are likely to open mildly in the green, extending the gains witnessed in Fridays session. Trends on SGX Nifty indicate a positive opening for the Nifty in India, with a 25-point gain. At 7:30 am, the Nifty futures were trading at 15,896 on the Singapore Stock Exchange. On Friday, the BSE Sensex had climbed 226.04 points to 52,925.04 and the Nifty gained 69.90 points to 15,860.40. S...